{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions zz"],"components":["Active, inactive s"],"effective_time":"20190509","id":"8878edb5-6d17-5633-e053-2995a90a1486","instructions_for_use":["Directions for use d"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1050-2 CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 2% / TAZAROTENE 0.05%. Gel 30gm d"],"set_id":"8878edb5-6d16-5633-e053-2995a90a1486","spl_product_data_elements":["CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% TAZAROTENE TAZAROTENE NIACINAMIDE NIACINAMIDE CLINDAMYCIN PHOSPHATE CLINDAMYCIN"],"version":"1"}